Thrombopoietin Stimulates Myelodysplastic Syndrome Granulocyte-Macrophage and Erythroid Progenitor Proliferation

References

• Hamblin T. Clinical feature of MDS. Leuk Res 1992; 16: 89–93
   PubMed Web of Science ®Google Scholar
• Wcisdorf D.J., Oken M.M., Johnson G.J., Rydell R.B. Chronic myclodysplastic syndrome: short survival with and without evolution to acute leukemia. Br J Haematol 1983; 59: 619–700
   Google Scholar
• Sanz G.F., Sanz M.A., Vallcspi T., Canizo M.C., Torrabadclla M., Garcia S., Irriguible D., San Miguel J.F. Two regression models and scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multi-variate analysis of prognostic factors in 370 patients. Blood 1989; 74: 395–408
   PubMed Web of Science ®Google Scholar
• Mufti G.J., Stevens J.R., Oscier D.G., Hamblin T.J., Machin D. Myelodysplastic syndromes: a scoring system with prognostic significance. Br J Haematol 1985; 59: 425–433
   PubMed Web of Science ®Google Scholar
• Cheson B.D., Simon R. Low-dose ARA-C in acute non lymphocytic leukemia and Myelodysplastic syndromes: a review of 20 years experience. Semin Oncol 1987; 14(suppl 1)126–133
   PubMedGoogle Scholar
• Estey B., Thall P., Kantarjian H., Pierce S., Beran M. Diagnosis of RAEB or RAEB-T, Rather than AML, does not negatively influence outcome of anti-AML chemotherapy. Blood 1996; 88(suppl I)292a, (abstract)
   Google Scholar
• Dunbar C., Nienhuis A.W. Myelodysplastic Syndromes. Blood: Principles and Practice of Hematology, R.I. Handin, S.E. Lux, T.P. Stossel. J. B. Lippincot, Philadelphia 1995; 377
   Google Scholar
• Anderson J.E., Appclbaum F.R., Fisher L.D., Schoch G., Shulman H., Anasetti C, Bensinger W.I., Bryant E., Buckner C.D., Doncy K., Martin P.J., Sanders J.E., Sullivan K.M., Thomas E.D., Whitherspoon R.P., Hansen J.A., Sturb R. Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome. Blood 1993; 82: 677–681
   PubMed Web of Science ®Google Scholar
• Ohno R., Naoe T., Hirano M., Kobayashi M., Hirai H., Tubaki K., Oh H. Treatment of myelodysplastic syndromes with all-trans retinoid acid. Blood 1993; 81: 1152–1154
   PubMed Web of Science ®Google Scholar
• Koeffler H.P., Hirji K., Itri L. 1.25-dihydroxyvi-tamin D3; in vivo and in vitro effects on human preleukemic and leukemic cells. Cancer Treat Rep 1985; 69: 1399–1407
   PubMedGoogle Scholar
• Cines C.B., Cassileth P.A., Kiss J.E. Danazol therapy in myelodysplasia. Ann Intern Med 1985; 103: 58–60
   PubMed Web of Science ®Google Scholar
• Negrin R., Stein R., Vardiman J., Doherty K., Cornwell J., Krantz S., Greenberg P.L. Treatment of the anemias of MDS using recombinant human granulocyte colony-stimulating factor. Blood 1993; 82: 737–743
   PubMed Web of Science ®Google Scholar
• Willemze R., van der Lely N., Zwierzina H., Suciu S., Solbu G., Gcrhartz H., Labar B., Visani G., Peetermans M.E., Jacobs A., Stryckmans P., Fenaux P., Haak H.L., Ribeiro M.M., Baumelou E., Baccarani M., Mandelli F., Jaksic B., Louwagie A., Thyss A., Hayat M., de Cataldo F., Stern A.C., Zittoun R. A randomized phase I/II multicenter study of recombinant human GM-CSF therapy for patients with myelodysplastic syndromes and a relative low risk to acute leukemia. Ann Hematol 1992; 64: 173–180
   PubMed Web of Science ®Google Scholar
• Ganser A., Ottman O.G., Seipelt G., Lindemann A., Hess U., Geissler G., Maurer A., Frisch J., Schilz G., Mertelsmann R., Hoelzer D. Effect of long-term treatment with recombinant human interIcukin-3 in patients with myelodysplastic syndromes. Leukemia 1993; 7: 696–701
   PubMed Web of Science ®Google Scholar
• Hellstrom E., Birgegaard G., Lockner D., Helmcrs C., Ost A., Wide L. Treatment of myelodysplastic syndromes with recombinant human erythropoietin. Eur J Haematol 1991; 47: 355–366
   PubMed Web of Science ®Google Scholar
• Kurzrock R., Talpaz M., Estey E., O'Brien S., Estrov Z., Gutterman J.U. Erythropoietin treatment in patients with myelodysplastic syndrome and anemia. Leukemia 1991; 5: 985–990
   PubMed Web of Science ®Google Scholar
• Cheson B.D. The Myelodysplastic Syndromes: Current approaches to therapy. Ann Intern Med 1990; 112: 932–941
   PubMed Web of Science ®Google Scholar
• Lok S., Kaushansky K., Holly R.D., Kuijper J.L., Lofton-Day C.E., Oort P.J., Grant F.J., Heipel M.D., Burkhead S.K., Kramer J.M., Bell L.A., Sprecher C.A., Blumberg H., Johnson R., Prunkard D., Ching A.F.T., Mathewes S.L., Bailey M.C., Forstrom J.W., Buddie M.M., Osborn S.G., Evans S.J., Sheppard P.O., Presnell S.R., O'Hara P.J., Hagcn F.S., Roth G.J., Foster D.C. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 1994; 369: 565–568
   PubMed Web of Science ®Google Scholar
• De Sauvage F.J., Hass P.E., Spenser S.D., Malloy B.E., Gurney A.L., Spencer S.A., Darbonne W.C., Henzcl W.J., Wong S.C., Kuang W.J., Oles K.J., Hultgren B., Solberg L.A., Goeddel D.V., Eaton D.L. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl lig-and. Nature 1994; 369: 533–538
   PubMed Web of Science ®Google Scholar
• Bartley T.D., Begenberger J., Hunt P., Li Y.S., Martin F., Chang M.S, Samal B., Nichol J.L, Swift S., Johnson M.J, Hsu R.Y, Parker V.P, Suggs S., Skrine J.D, McRewether L.A, Clogston C., Hsu E., Hokom M.M, Hornkohl A., Choi E., Pangelinan M., Sun Y., Mar V., McNinch J., Simonet L., Jacobsen F., Xie C., Shutter J., Chute H., Basu R., Selander L., Trollinger S.D, Sieu L., Padilla D., Trail G., Elliott G., Izumi R., Covey T., Crouse J., Garcia A., Xu W., Del Castillo J., Biron J., Cole S., Hu M.C.T., Pacifici R., Poming I., Saris C., Wen D., Yung Y.P, Lin H., Bosselman A. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 1994; 77: 1117–1124
   PubMed Web of Science ®Google Scholar
• Miyazaki H., Kato T., Ogami K., Iwamatsu A., Shimada Y., Souma Y., Akahori H., Horie K., Kokubo A., Kudo Y., Maeda E., Kawamura K., Sudo T. Isolation and cloning of a novel thrombopoietic factor. Exp Hematol 1994; 22: 838–846
   Web of Science ®Google Scholar
• Kaushansky K. Thrombopoietin: the primary regulator of platelet production. Blood 1995; 86: 419–431
   PubMed Web of Science ®Google Scholar
• Papayannopoulou T. Biological effects of thrombopoietin, the Mpl ligand, and its therapeutic potential. Cancer Chemother Pharmacol 1996; 38: S69–S73
   PubMed Web of Science ®Google Scholar
• Debili N., Wendling F., Katz A., Guichard J., Breton-Gorius J., Hunt P., Vainchenker W. The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood 1995; 86: 2516–2521
   PubMed Web of Science ®Google Scholar
• Kaushansky K., Broudy V.C., Lin N., Jorgensen M.J., McCarty J., Fox N., Zucker-Franklin D., Lofton-Day C. Thrombopoietin, the Mpl ligand, is essential for full megakaryocyte development. Proc Natl Acad Sci USA 1995; 92: 3234–3239
   PubMed Web of Science ®Google Scholar
• Kobayashi M., Laver J.H., Kato T., Miyazaki H., Ogawa M. Recombinant human thrombopoietin (Mpl ligand) enhances proliferation of erythroid progenitors. Blood 1995; 86: 2494–2499
   PubMed Web of Science ®Google Scholar
• Kaushansky K., Broudy V.C., Grossman A., Humes J., Lin N., Hong P., Sprugel K.H., Bailey M.C., Papayannopoulou T., Forstrom J. Thrombopoietin expands erythroid progenitors, increases red cell production and enhances erythroid recovery following myelosuppressive therapy. J Clin Invest 1995; 96: 1683–1693
   PubMed Web of Science ®Google Scholar
• Papayannopoulou T., Brice M., Farrer D., Kaushansky K. Insights into cellular mechanism of erythropoietin-tlirombopoietin synergy. Exp Hematol 1996; 24: 60–664
   Google Scholar
• Drexler H.G., Quentmeier H. Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells. Leukemia 1996; 10: 1405–1421
   PubMed Web of Science ®Google Scholar
• Chadwick D.E., Williams D.P., Niho Y., Murphy J.R., Minden M.D. Cytotoxicity of a recombinant diphtheria toxin-granuiocyte colony-stimulating factor fusion protein on human leukemic blast cells. Leukemia and Lymphoma 1993; 11: 249–262
   PubMed Web of Science ®Google Scholar
• Papayannopoulou T., Nakamoto B., Kurachi S., Tweeddale M., Messner H. Surface antigen profile and globin phenotype of two new human erythroleukemia lines: characterization and interpretations. Blood 1988; 72: 1029–1038
   PubMed Web of Science ®Google Scholar
• Shaw G.M., Levy P.C., Lo Buglio A.F. Human monocyte antibody-dependent cell-medicated cytotoxicity to tumor cells. J Clin Invest 1978; 62: 1172–1180
   PubMed Web of Science ®Google Scholar
• Estrov Z., Grunberger T., Chan H.S.L., Freeman M.H. Juvenile Chronic Myelogenous Leukemia: characterization of the disease using cell cultures. Blood 1986; 67: 1382–1387
   PubMed Web of Science ®Google Scholar
• Strauss L.C., Trischmann T.M., Rowley S.D., Wiley J.M., Civin C.I. Selection of normal human hematopoietic stem cells for bone marrow transplantation using immunomagnetic microspheres and CD34 antibody. Am J Pediatr Hematol Oncol 1991; 13: 217–221
   PubMedGoogle Scholar
• Bertoncello I., Bradley R., Watt S.M. An improved negative immunomagnetic selection strategy for the purification of primitive hemopoietic cells from normal bone marrow. Exp Hematol 1991; 19: 95–100
   PubMed Web of Science ®Google Scholar
• Re G.G., Estrov Z., Antoun G.R., Felix E.A., Pinkel D.P., Zipf T.F. Differentiation in B-precursors acute lymphoblastic leukemia cell population with CD34-positive subpopulations. Blood 1991; 78: 575–580
   PubMed Web of Science ®Google Scholar
• Fauser A.A., Messner H.A. Granuloerythropoietic colonies in human bone marrow, peripheral blood, and cord blood. Blood 1978; 52: 1243–1248
   PubMed Web of Science ®Google Scholar
• Messner H.A., Fauser A.A. Culture studies of human pluripotent hematopoietic progenitors. Blut 1980; 41: 327–333
   PubMedGoogle Scholar
• Estrov Z., Cohen A., Gelfand E.W., Freedman M.H. Synergistic antiproliferative effects on HL-60 cells: deferoxamine enhances cytosine-arabinoside, methotrexate and daunorubicine cytotoxicity. Am. J Pediatr Hematol Oncol 1988; 10: 288–291
   PubMedGoogle Scholar
• Buick R.N., Till J.E., McCulloch E.A. A colony assay for proliferative blast cells circulating in myeloblasts leukemia. Lancet 1977; 1: 862–864
   PubMed Web of Science ®Google Scholar
• Minden M.D., Buick R.N., McCulloch E.A. Separation of blast cells and T lymphocyte progenitors in the blood of patients with acute myeloblasts leukemia. Blood 1979; 54: 186–189
   PubMed Web of Science ®Google Scholar
• Freedman M.H., Chan H.S.L., Chang L. Childhood erythroleukemia. Studies on pathogenesis using colony assays. Am J Pediatr Hematol Oncol 1986; 8: 2–9
   PubMedGoogle Scholar
• Foster D.C., Sprecher C.A., Grant F.J., Kramer J.M., Kuijper, Holly R.D., Whitmore T.E., Heipel M.D., Bell L.A., Ching A.F. Human thrombopoietin: gene structure, c-DNA sequence, expression and chromosomal localization. Proc Natl Acad Sci USA 1994; 91: 13023–13027
   PubMed Web of Science ®Google Scholar
• Sohma Y., Akahori H., Seki N., Hori T.A., Ogami K., Kato T., Shimada Y., Kawaruma K., Miyazaki H. Molecular cloning and chromosomal localization of the human thrombopoietin gene. FEBS Lett 1994; 353: 57–61
   PubMed Web of Science ®Google Scholar
• Suzukawa K., Satoh H., Tanikawi M., Yokota J., Morishita K. The human thrombopoietin gene is located on chromosome 3q 26.33-q27, but is not transcriptionally activated in leukemia cells with 3q21 and 3q26 abnormalities (3q21q26 syndrome). Leukemia 1995; 9: 1328–1331
   PubMed Web of Science ®Google Scholar
• Alexander W.S., Roberts A.W., Nicola N.A., Li R., Metcalf D. Deficiencies in progenitor cells multiple hematopoietic lineages and defective megakaryocytopoisis in mice lacking the thrombopoietin receptor c-Mpl. Blood 1996; 87: 2162–2170
   PubMed Web of Science ®Google Scholar
• Matsumura I., Kanakura Y., Kato T., Ikeda H., Ishikawa J., Horikawa Y., Hashimoto K., Moriyama Y., Tsujimura T., Nishiura T., Miyazaki H., Matsuzawa Y. Growth response of acute myeloblastic leukemia cells to recombinant human thrombopoietin. Blood 1995; 86: 703–709
   PubMed Web of Science ®Google Scholar
• Quentmeier H., Zaborski M., Graf G., Ludwig W.D., Drexler H.G. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemic cell lines. Leukemia 1996; 10: 297–310
   PubMed Web of Science ®Google Scholar
• Matsumura I., Kanakura Y., Kato T., Ikeda H., Horikawa Y., Ishikawa J., Kitayama H., Nishiura T., Tomiyama Y., Miyazaki H., Matsuzawa Y. The biological properties of recombinant human thrombopoietin in the proliferation and megakaryocyte differentiation of acute myeloblastic leukemia cells. Blood 1996; 88: 3074–3082
   PubMed Web of Science ®Google Scholar
• Motoji T., Takanashi M., Motomura S., Yan-Hua W., Shiozaki H., Aoyama M., Mizoguchi H. Growth stimulatory effect of thrombopoietin in the blast cells of acute myelogenous leukemia. Br J Haematol 1996; 94: 513–516
   PubMed Web of Science ®Google Scholar